Unlocking Early Diagnosis of Brain Disorders Through Liquid Biopsies

Researchers from Harvard have developed a groundbreaking technique to detect early biomarkers for brain disorders such as Parkinson's and Alzheimer's in blood samples, potentially allowing for early diagnosis and treatment. This method focuses on analyzing purified extracellular vesicles (EVs), solving the problem of distinguishing between proteins contained within EVs and those bound externally.